CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
19.50
+0.34 (1.77%)
At close: Mar 17, 2026, 4:00 PM EDT
19.50
0.00 (0.00%)
After-hours: Mar 17, 2026, 4:10 PM EDT
CeriBell Revenue
In the year 2025, CeriBell had annual revenue of $89.06M with 36.09% growth. CeriBell had revenue of $24.78M in the quarter ending December 31, 2025, with 33.72% growth.
Revenue (ttm)
$89.06M
Revenue Growth
+36.09%
P/S Ratio
8.27
Revenue / Employee
$272,364
Employees
327
Market Cap
734.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 89.06M | 23.62M | 36.09% |
| Dec 31, 2024 | 65.44M | 20.22M | 44.71% |
| Dec 31, 2023 | 45.23M | 19.30M | 74.47% |
| Dec 31, 2022 | 25.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCBLL News
- 20 days ago - CeriBell, Inc. (CBLL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 27 days ago - Ceribell to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 5 weeks ago - Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 2 months ago - CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution - GlobeNewsWire
- 2 months ago - Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution - GlobeNewsWire